Anergis’ technology of Contiguous Overlapping Peptides derives from original patents filed jointly by the University of Lausanne (UNIL), the University Hospital of Lausanne (CHUV) and the Federal Polytechnic School of Lausanne (EPFL), based on innovative research performed by Prof. Spertini in his laboratory.

Anergis acquired the above patents from UNIL/CHUV/EPFL in 2005 and has built a strong intellectual property portfolio including composition-of-matter patents for its product candidates.



  • Biopôle Building SC-A
    Route de la Corniche 4
    CH-1066 Epalinges
  • Email:

This website uses cookies to ensure you get the best experience on our website.